Rifampicin

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instanceOf gptkb:antibiotic
gptkbp:affiliatedWith rifamycins
gptkbp:alsoKnownAs gptkb:rifampin
gptkbp:approvalYear 1971
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode gptkb:J04AB02
gptkbp:chemicalFormula C43H58N4O12
gptkbp:combinationTherapy gptkb:isoniazid
gptkb:ethambutol
gptkb:pyrazinamide
streptomycin
gptkbp:contraindication hypersensitivity to rifamycins
gptkbp:discoveredBy gptkb:Piero_Sensi
Grazia Timbal
gptkbp:discoveredIn 1965
gptkbp:drugInteraction gptkb:warfarin
anticonvulsants
protease inhibitors
oral contraceptives
gptkbp:eliminationHalfLife 3-5 hours
gptkbp:excretion urine
bile
gptkbp:firstSynthesized 1965
https://www.w3.org/2000/01/rdf-schema#label Rifampicin
gptkbp:inducedBy gptkb:cytochrome_P450_enzymes
gptkbp:lactationUse caution advised
gptkbp:legalStatus prescription only
gptkbp:marketedAs gptkb:Pfizer
gptkb:Sanofi
gptkb:Sandoz
gptkbp:mechanismOfAction inhibits bacterial DNA-dependent RNA polymerase
gptkbp:metabolism liver
gptkbp:molecularWeight 822.94 g/mol
gptkbp:origin gptkb:Streptomyces_mediterranei
gptkbp:overdoseSymptoms nausea
vomiting
jaundice
unconsciousness
gptkbp:pregnancyCategory C (US)
use only if clearly needed
gptkbp:riskOfResistance high if used as monotherapy
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect rash
hepatotoxicity
gastrointestinal upset
flu-like syndrome
orange-red discoloration of body fluids
gptkbp:usedFor gptkb:Staphylococcus_aureus_infections
tuberculosis
brucellosis
leprosy
Legionnaires' disease
meningococcal prophylaxis
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:D014244
gptkbp:bfsLayer 7